In August, a large number of pharmaceutical companies announced that their products passed the consistency evaluation. Northeast Pharmaceuticals, Lianhuan Pharmaceuticals, etc.

[Pharmaceutical Network Industry News] Passing the consistency evaluation of generic drugs has been regarded as a "ticket" to participate in centralized procureme.
With the normalization of centralized procurement, domestic pharmaceutical companies are actively promoting product over-evaluati.
Since August alone, a large number of pharmaceutical companies have announced good news that their products have passed the consistency evaluation, involving Northeast Pharmaceuticals, Lianhuan Pharmaceuticals,e.
Northeast Pharmaceuticals: Over-evaluation of L-carnitine Injection On August 6, Northeast Pharmaceuticals announced that the company's L-carnitine injection (5ml:1g) passed the quality and efficacy consistency evaluation of generic dru.
The drug is suitable for a series of complications caused by secondary carnitine deficiency in chronic renal failure patients on long-term hemodialys.
spasmse.
Bihuan Pharmaceutical: Drotaverine Hydrochloride Injection was over-reviewed and won the first one On August 5, Bihuan Pharmaceutical announced that the company's Drotaverine Hydrochloride Injection has recently passed the quality and efficacy consistency evaluation of generic dru.
The drug is a specific smooth muscle antispasmodic drug, which is mainly used to treat smooth muscle spasm associated with biliary tract diseases (gallbladder/biliary calculi, gallbladder/cholangitis, e.
), urinary system diseases (kidney/ureteral calculi, renal pelvis/cystitis, e.
Inflammation) caused by smooth muscle spasm,e.
At present, there are only 3 domestic manufacturers of the same variety, and Lianhuan Pharmaceutical is the first company to pass the consistency evaluation of this varie.
Zhejiang Medicine: Over-evaluation of Ciprofloxacin Hydrochloride Tablets On August 4, Zhejiang Medicine announced that the company's Ciprofloxacin Hydrochloride Tablets (25g) passed the quality and efficacy consistency evaluation of generic dru.
The drug is a third-generation quinolone antibacterial drug, suitable for the treatment of lower respiratory tract infection caused by Gram-negative bacteria in adults, bronchopulmonary infection in cystic fibrosis or bronchiectasis, pneumonia, chronic suppurative otitis media, urinary tract infection infections, complicated urinary tract infections,e.
At present, there are 89 domestic manufacturers of ciprofloxacin hydrochloride table.
As of the date of this announcement, a total of 4 manufacturers have passed the consistency evaluation of this varie.
Up to now, the company has invested about 67 million yuan in research and development expenses for the consistency evaluation of ciprofloxacin hydrochloride table.
Yuekang Pharmaceutical: Over-evaluation of Azithromycin for Injection On August 3, Yuekang Pharmaceutical announced that the company's azithromycin for injection (5g) passed the consistency evaluation of generic drug quality and effica.

The drug belongs to macrolide antibiotics, and has good antibacterial effect on most Gram-positive bacteria, Legionella, Chlamydia, Mycoplasma, and anaerobic bacter.

According to data from Min.

com, the annual sales trend of sample hospitals in China (urban public) in 2021 shows that the sales of azithromycin for injection will be 453 million yu.

Lifang Pharmaceutical: Over-evaluation of Felodipine Sustained-Release Tablets On August 3, Lifang Pharmaceutical announced that recently, the company's Felodipine Sustained-Release Tablets passed the quality and efficacy consistency evaluation of generic dru.

The drug is mainly used for the treatment of hypertension and stable angina pector.

It is reported that the product (specification: 5mg) of Lifang Pharmaceutical obtained the approval for drug registration and production in 2004, and then submitted a supplementary application for consistency evaluation of felodipine sustained-release tablets to the Center for Drug Evaluation of the State Drug Administration in August 202 and accepted on August 30, 202As of the announcement date, in addition to the original research, there are 4 domestic companies that have passed/deemed to pass the consistency evaluation of quality and efficacy of felodipine sustained-release table.

 　　Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyo.